Effects of hormone therapy containing 2 mg drospirenone and 1 mg 17β-estradiol on postmenopausal exacerbation of Meniere's disease: Preliminary study.
17β-estradiol
Meniere's disease
drospirenone
hormone therapy
menopause
stabilometry
Journal
Experimental and therapeutic medicine
ISSN: 1792-1015
Titre abrégé: Exp Ther Med
Pays: Greece
ID NLM: 101531947
Informations de publication
Date de publication:
Oct 2021
Oct 2021
Historique:
received:
27
02
2021
accepted:
06
07
2021
entrez:
10
9
2021
pubmed:
11
9
2021
medline:
11
9
2021
Statut:
ppublish
Résumé
The present study aimed to evaluate the effects of 2 mg drospirenone (DRSP) and 1 mg 17β-estradiol (E2) hormone therapy (HT) in combination with rehabilitation therapy for postmenopausal women with Meniere's disease (MD). The combined drug hormone treatment was denoted as DRSP/E2. A total of 65 postmenopausal female patients with MD and severe distress were enrolled in the present prospective study. A total of 31 women comprised the study group (group A), undergoing HT and rehabilitation therapy, whereas 34 women who opted for rehabilitation therapy alone comprised the control group (group B). Vestibular function and distress associated with MD were assessed by stabilometry and the Dizziness Handicap Inventory (DHI) questionnaire, respectively. The data were collected at baseline and during the 3- and 6-month follow-up visits. The areas of the stabilometric ellipses exhibited a higher reduction in group A compared with group B with regard to the baseline values at both follow-up assessments (P<0.001). At baseline, both groups exhibited severe self-perceived discomfort, with similar DHI scores of 72.3±3.7 (group A) and 70.6±3.9 (group B; P=0.07). At the 3-month follow-up, both groups underwent a gradual improvement, which was significantly higher in group A (47.5±3.7) compared with in group B (64.2±3.3; P<0.001). At the 6-month follow-up, the DHI scores were improved in group A (43.4±3.4) compared with in group B (58.5±3.1; P<0.001). Therefore, DRSP/E2 HT was effective in reducing the fluid overload, which is characteristic of MD. The findings of the present study demonstrated that integrated therapy based on the administration of DRSP/E2 HT and rehabilitation may be more effective compared with rehabilitation alone for the management of postmenopausal exacerbation of MD.
Identifiants
pubmed: 34504557
doi: 10.3892/etm.2021.10537
pii: ETM-0-0-10537
pmc: PMC8383771
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1103Informations de copyright
Copyright: © Grillo et al.
Déclaration de conflit d'intérêts
The authors declare that they have no competing interests.
Références
Obstet Gynecol Surv. 2009 Jan;64(1):58-72
pubmed: 19099613
Arch Otolaryngol Head Neck Surg. 1990 Apr;116(4):424-7
pubmed: 2317323
Neuroscience. 2008 Jun 2;153(4):881-900
pubmed: 18440718
Hear Res. 2009 Jun;252(1-2):1-2
pubmed: 19531444
Acta Otolaryngol. 1981 May-Jun;91(5-6):511-4
pubmed: 7270122
Maturitas. 2006 Nov 20;55(4):297-307
pubmed: 16949774
IEEE Trans Biomed Eng. 1996 Sep;43(9):956-66
pubmed: 9214811
Am Fam Physician. 2017 Feb 1;95(3):154-162
pubmed: 28145669
Climacteric. 2000 Sep;3(3):192-8
pubmed: 11910621
JAMA. 2002 Aug 21;288(7):872-81
pubmed: 12186605
Climacteric. 2016 Apr;19(2):109-50
pubmed: 26872610
Agressologie. 1983 Jun;24(7):321-6
pubmed: 6638321
Ther Clin Risk Manag. 2015 Feb 25;11:301-7
pubmed: 25750534
Acta Otolaryngol. 2017 Jan;137(1):63-70
pubmed: 27683970
Climacteric. 2005 Oct;8 Suppl 3:4-12
pubmed: 16203650
J Endocrinol Invest. 2019 May;42(5):609-618
pubmed: 30456623
J Clin Endocrinol Metab. 2007 Aug;92(8):3060-7
pubmed: 17550960
Otolaryngol Head Neck Surg. 2020 Apr;162(2_suppl):S1-S55
pubmed: 32267799
Adv Otorhinolaryngol. 1988;42:290-3
pubmed: 3213745
Menopause. 2008 Sep-Oct;15(5):967-72
pubmed: 18551084
J Vestib Res. 2015;25(1):1-7
pubmed: 25882471
Front Aging Neurosci. 2017 Dec 12;9:404
pubmed: 29311896
J Neuroendocrinol. 2007 Nov;19(11):901-6
pubmed: 17927668
Climacteric. 2000 Mar;3(1):50-8
pubmed: 11910610
Auris Nasus Larynx. 2017 Apr;44(2):156-161
pubmed: 27423924
Menopause. 2000 May-Jun;7(3):178-83
pubmed: 10810963
Neurology. 1999 Dec 10;53(9):2069-72
pubmed: 10599783
BMC Neurol. 2014 May 20;14:110
pubmed: 24886504
Auris Nasus Larynx. 2017 Feb;44(1):52-57
pubmed: 27033030
Climacteric. 2007 Feb;10 Suppl 1:3-10
pubmed: 17364592
Eur J Obstet Gynecol Reprod Biol. 2018 May;224:102-107
pubmed: 29573626
Ann Intern Med. 2005 Jun 21;142(12 Pt 1):1003-13
pubmed: 15968015
Climacteric. 2005 Oct;8 Suppl 3:28-34
pubmed: 16203653
J Clin Lab Anal. 2019 Jan;33(1):e22626
pubmed: 30030864
Fertil Steril. 2003 Mar;79(3):556-61
pubmed: 12620439
Nursing. 2017 Jul;47(7):38-45
pubmed: 28594693
Audiol Neurootol. 2017;22(2):74-82
pubmed: 28723686
ORL J Otorhinolaryngol Relat Spec. 2005;67(5):305-9
pubmed: 16374065